Viewing Study NCT00005467



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00005467
Status: COMPLETED
Last Update Posted: 2016-02-18
First Post: 2000-05-25

Brief Title: Indices of Severity and Prognosis for Sickle Cell Disease
Sponsor: National Heart Lung and Blood Institute NHLBI
Organization: National Heart Lung and Blood Institute NHLBI

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2000-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To develop a clinical severity index that could prospectively identify sickle cell disease patients who were at high risk for a turbulent clinical course and a poor prognosis
Detailed Description: DESIGN NARRATIVE

Using the database univariate analysis showed that factors associated with the occurrence of cerebrovascular accident 51 patients included hematocrit rate of change of pocked red cell count and polymer fraction at 40 percent oxygen saturation PF40 Only low hematocrit was predictive of death in the pediatric cohort There were 45 disease-related deaths

The study completion date listed in this record was obtained from the End Date entered in the Protocol Registration and Results System PRS record

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
R01HL042498 NIH None httpsreporternihgovquickSearchR01HL042498